dc.contributor.author | Hartl, Dominik | |
dc.date.accessioned | 2021-10-28T09:16:40Z | |
dc.date.available | 2021-10-28T09:16:40Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | http://hdl.handle.net/10900/120193 | |
dc.language.iso | en | de_DE |
dc.publisher | Frontiers Media Sa | de_DE |
dc.relation.uri | http://dx.doi.org/10.3389/fimmu.2021.697405 | de_DE |
dc.subject.ddc | 570 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19 | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20210824232002_00657 | |
utue.personen.roh | Rowlands, Marianna | |
utue.personen.roh | Segal, Florencia | |
utue.personen.roh | Hartl, Dominik | |
dcterms.isPartOf.ZSTitelID | Frontiers in Immunology | de_DE |
dcterms.isPartOf.ZS-Issue | Article 697405 | de_DE |
dcterms.isPartOf.ZS-Volume | 12 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |